Predictors of Mortality in Patients with Idiopathic Pulmonary Fibrosis (IPF)

被引：0

作者：

du Bois, R. ^{[1
]}

Albera, C. ^{[2
]}

Bradford, W. ^{[3
]}

Costabel, U. ^{[4
]}

Hormel, P. ^{[3
]}

King, T., Jr. ^{[5
]}

Noble, P. ^{[6
]}

Szwarcberg, J. ^{[3
]}

Thomeer, M. ^{[7
]}

Valeyre, D. ^{[8
]}

Weycker, D. ^{[9
]}

机构：

[1] Natl Jewish, Denver, CO USA

[2] Univ Turin, Turin, Italy

[3] InterMune Inc, Brisbane, CA USA

[4] Ruhrlandklinik, Essen, Germany

[5] UCSF, San Francisco, CA USA

[6] Duke Univ, Durham, NC USA

[7] Univ Hosp Gasthuisberg, B-3000 Louvain, Belgium

[8] Assistance Publ Hop, Paris, France

[9] Policy Anal Inc, Brookline, MA USA

来源：

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2009年 / 179卷

关键词：

D O I：

暂无

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

A1114

引用

页数：1

共 50 条

[41] IDIOPATHIC PULMONARY FIBROSIS AND PULMONARY HYPERTENSION: PREDICTORS OF MORTALITY AND IMPACT ON OUTCOMES
Halawa, Abdul Rahman
Rao, Adishwar
Agrawal, Akriti
Abrencillo, Rodeo A.
Kazzaz, Farah I.
Hussain, Rahat
Quintana, Harry Karmouty
Patel, Bela
Akkanti, Bindu
CHEST, 2024, 166 (04) : 5940A - 5941A
[42] A Novel Clinical Prediction Model For Near-Term Mortality In Patients With Idiopathic Pulmonary Fibrosis (ipf)
Du Bois, R. M.
Albera, C.
Bradford, W. Z.
Costabel, U.
Noble, P. W.
Sahn, S. A.
Valeyre, D.
Weycker, D.
King, T. E.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
[43] Exacerbations, hospitalisations and mortality in patients with idiopathic pulmonary fibrosis in clinical practice: INSIGHTS-IPF registry
Behr, Juergen
Pittrow, David
Prasse, Antje
Wirtz, Hubert
Koschel, Dirk
Andreas, Stefan
Claussen, Martin
Grohe, Christian
Wilkens, Heinrike
Hagmeier, Lars
Skowasch, Dirk
Meyer, F. Joachim
Kirschner, Joachim
Glaser, Sven
Herth, Felix J. F.
Welte, Tobias
Neurohr, Claus
Schwaiblmair, Martin
Held, Matthias
Bahmer, Thomas
Geier, Silke
Klotsche, J. Ens
Frankenberger, Marion
Kreuter, Michael
EUROPEAN RESPIRATORY JOURNAL, 2017, 50
[44] The circulating metabolome in idiopathic pulmonary fibrosis (IPF)
Hesslinger, Christian
Overton, Robert
Keller, Sascha
Neely, Megan L.
Belperio, John A.
Vinisko, Richard
Leonard, Thomas
Flaherty, Kevin R.
Noth, Imre
Palmer, Scott M.
Todd, Jamie L.
EUROPEAN RESPIRATORY JOURNAL, 2019, 54
[45] Idiopathic pulmonary fibrosis (IPF) and gastroeosophageal disorders
Kokeza, Josipa
Mise, Kornelija
Puljiz, Zeljko
Bradaric, Anteo
Lozo, Emilija
Mise, Josko
EUROPEAN RESPIRATORY JOURNAL, 2013, 42
[46] Idiopathic pulmonary fibrosis (IPF): the patient journey
Cottin, Vincent
Bonella, Francesco
Small, Mark
Siddall, James
Langley, Jonathan
Inoue, Yoshikazu
Lancaster, Lisa
EUROPEAN RESPIRATORY JOURNAL, 2020, 56
[47] CLINICAL CHARACTERISTICS OF PATIENTS REFERRED TO THE IDIOPATHIC PULMONARY FIBROSIS (IPF) REGISTRY
SMITH, CM
PICCHI, MA
RIES, AL
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1993, 147 (04): : A590 - A590
[48] Autoantibodies against Th/To antigen in patients with idiopathic pulmonary fibrosis (IPF).
Brown, KK
Taddei, SC
West, SG
King, TE
Schwarz, MI
Feghali, CA
Wright, TM
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : A68 - A68
[49] Cognitive Function (CF) Is Impaired in Patients with Idiopathic Pulmonary Fibrosis (IPF)
Sprunger, D. B.
Talbert, J. L.
Brown, K. K.
Swigris, J. J.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
[50] Survival in Patients with Idiopathic Pulmonary Fibrosis (IPF): Data from the IPF-PRO Registry
Palmer, S. M.
Snyder, L.
Neely, M. L.
Yow, E.
Bender, S.
Culver, D. A.
de Andrade, J.
Gulati, M.
Kaner, R. J.
Leonard, T.
O'Brien, E.
Pushlar, N.
Conoscenti, C. S.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197

← 1 2 3 4 5 →